Anti-obesity drugs fuel Babybel's US boom

Anti-obesity drugs fuel Babybel's US boom
Bel, the French family-owned company, plans to invest €60 million in a second Babybel production line at its Sablé-sur-Sarthe factory in eastern France and is considering expanding its American facility.